{"ok":true,"trend":{"id":760421,"platform":"x","region":"SE","key":"viking therapeutics shares hover near $30 amid obesity drug competition","title":"Viking Therapeutics Shares Hover Near $30 Amid Obesity Drug Competition","url":"https://x.com/search?q=Viking%20Therapeutics%20Shares%20Hover%20Near%20%2430%20Amid%20Obesity%20Drug%20Competition&src=trend_click","first_seen":"2026-10-02T17:38:28.150037Z","last_seen":"2026-10-02T18:23:33.047402Z","last_rank":32,"peak_rank":32,"last_volume":53,"peak_volume":53,"seen_count":4,"score":4.51125,"category_hint":"Trending now","section":null,"category":null,"summary":"Viking Therapeutics stock is trading close to the $30 mark as investors weigh the company's prospects in the increasingly crowded obesity drug market. The biotech, developing GLP-1-based treatments, is being watched closely against larger rivals such as Eli Lilly and Novo Nordisk, and market watchers are debating whether its obesity pill candidates can compete.","why":"Investors are tracking the stock as competition intensifies in the fast-growing obesity drug market.","tone":"neutral","entities":["Viking Therapeutics","Eli Lilly","Novo Nordisk"],"summarized_at":"2026-10-02T17:40:25.094678Z","meta":{"lang":"en","explore":true},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Viking Therapeutics Shares Hover Near $30 Amid Obesity Drug Competition","timeline":[{"captured_at":"2026-10-02T17:38:28.150037Z","rank":33,"volume":34},{"captured_at":"2026-10-02T17:53:28.147422Z","rank":33,"volume":39},{"captured_at":"2026-10-02T18:08:28.357227Z","rank":32,"volume":43},{"captured_at":"2026-10-02T18:23:33.047402Z","rank":32,"volume":53}],"posts":[],"elsewhere":[],"window":"7d"}}